CCR7 and mantle cell lymphoma: Administration of an antibody against CCR7, a chemokine receptor known to cause lymphoid dissemination in many cancers, suppressed dissemination of MCL cells and reduced mortality in an animal model, suggesting the importance of TME in the pathogenesis and aggressiveness of MCL [35].